These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15358437)

  • 1. Role of stress in the pathogenesis of the metabolic syndrome.
    Rosmond R
    Psychoneuroendocrinology; 2005 Jan; 30(1):1-10. PubMed ID: 15358437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
    Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
    Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
    Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
    Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep and the metabolic syndrome.
    Wolk R; Somers VK
    Exp Physiol; 2007 Jan; 92(1):67-78. PubMed ID: 17085678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background and treatment of metabolic syndrome: a therapeutic challenge.
    van Zwieten PA; Mancia G
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):206-14. PubMed ID: 16959752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology of the metabolic syndrome: an allostatic perspective.
    van Dijk G; Buwalda B
    Eur J Pharmacol; 2008 May; 585(1):137-46. PubMed ID: 18395710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome.
    Fransson L; Franzén S; Rosengren V; Wolbert P; Sjöholm Å; Ortsäter H
    J Endocrinol; 2013 Dec; 219(3):231-41. PubMed ID: 24048967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress mechanisms and metabolic complications.
    Kyrou I; Tsigos C
    Horm Metab Res; 2007 Jun; 39(6):430-8. PubMed ID: 17578760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
    Alam I; Lewis K; Stephens JW; Baxter JN
    Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance (metabolic) syndrome in children.
    Rosenberg B; Moran A; Sinaiko AR
    Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress, visceral obesity, and metabolic complications.
    Kyrou I; Chrousos GP; Tsigos C
    Ann N Y Acad Sci; 2006 Nov; 1083():77-110. PubMed ID: 17148735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic determinants of the metabolic syndrome.
    Pollex RL; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):482-9. PubMed ID: 16932765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep apnea is a manifestation of the metabolic syndrome.
    Vgontzas AN; Bixler EO; Chrousos GP
    Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.